Pathology Doctors in Ponce, PR Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Dr. Michael Chibaka Awasum, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 234-a Parque Industrial Sabaneta, Ponce, PR 00716 Phone: 787-841-8645    Fax: 787-848-4043

Dr. Joseph Kevin Dowden, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: Southern Pathology Services, 234-a Sabaneta Industrial Park, Ponce, PR 00716 Phone: 787-651-0898    Fax: 787-843-3464

Edgar Carlos Belmonte, MD Pathology - Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 234a Sabaneta Industrial Park, Ponce, PR 00716 Phone: 787-841-8645

Dr. Adalberto Mendoza, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Ponce, Parque Industrial Sabanetas, Ponce, PR 00715 Phone: 787-841-8640    Fax: 787-843-3464

Mr. Jose Oscar Santiago Alvarado Sr., MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: Condominio San Vicente 8169, Calle Concordia Suite 305, Ponce, PR 00717 Phone: 787-842-7981    Fax: 787-840-4296

News Archive

New immunotherapy treatment for cancer patients is more effective and less dangerous

Cell toxicity during immunotherapy is a major limitation to cancer treatment.

Overweight, smoking add to rheumatoid arthritis risk

Lifestyle changes could reduce the risk for rheumatoid arthritis in patients predisposed to the condition, Dutch researchers suggest.

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced today that the U.S. Food and Drug Administration (FDA) has licensed the company's newest vaccine filling and packaging facility, located in Kankakee, Ill. The facility, part of an investment to expand CSL's U.S. influenza vaccine production capabilities, includes a high-speed, single-dose vaccine syringe filling line.

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant

Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

GTEx findings reveal how genomic variants can affect gene activity and disease susceptibility

Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease.

Read more Medical News

› Verified 9 days ago